“罕见病第一股”今年涨幅超1400%!

每日经济新闻
Aug 13

8月13日开盘,北海康成股价大涨,截至收盘涨25.75%。今日早间,公司宣布了战略融资事项以及与百洋医药的独家商业服务协议,后者的附属公司将作为独家合同销售组织(CSO),在内地、香港及澳门推广北海康成的若干产品。前一日,公司两款产品一齐出现在国家医保局公示的商保创新药目录初审名单中。8月13日,百洋医药方面对《每日经济新闻》记者表示,公司非常看好罕见病赛道,公司将与北海康成一起拓展并丰富罕见病...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10